|
|
|
|
LEADER |
00962cas#a2200313#a#4500 |
001 |
018142 |
005 |
20160923115331.0 |
008 |
060908s1983####xxumu#p#######0###a|eng#d |
022 |
|
|
|a 0732-183X
|
030 |
|
|
|a JCONDN
|
040 |
|
|
|a AR-beUNQ
|
099 |
|
|
|a P-US-JOU20
|
210 |
1 |
0 |
|a J. clin. oncol.
|
245 |
1 |
0 |
|a Journal of Clinical Oncology
|c American Society of Clinical Oncology.
|
246 |
1 |
3 |
|a Clinical Oncology
|
246 |
1 |
3 |
|a Clinical Oncology
|
260 |
|
|
|a Philadelphia, PA :
|b W. B. Saunders Company,
|
300 |
|
|
|a v. :
|
310 |
|
|
|a Mensual
|
362 |
0 |
|
|a Vol. 11 no. 7 (Jul. 1993)-
|
500 |
|
|
|a Descripción basada:Vol. 11 no. 7 (Jul. 1993).
|
650 |
|
7 |
|a Neoplasmas malignos
|2 Spines
|
650 |
|
7 |
|a Terapéutica
|2 Spines
|
650 |
|
7 |
|a Cáncer
|2 toit
|
653 |
|
|
|a Oncología
|
710 |
2 |
|
|a American Society of Clinical Oncology.
|
866 |
|
0 |
|a 1993 11(7)
|
929 |
|
|
|d 0
|b Laboratorio de Oncología Molecular
|a DONACION
|j 38938 00001
|e 20050526
|
999 |
|
|
|c 27466
|d 110272
|